Frontlight ResearchEarly access
Triple-negative breast cancer trials in United States
172 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleDendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- Where
- Buffalo, Charlottesville, Tampa
- Age
- 18 years and over
- People
- 23
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT04348747 - Phase 2Taking peopleSacituzumab Govitecan In TNBC
- Where
- Boston, Danvers, Newton
- Age
- 18 years and over
- People
- 239
- Run by
- Massachusetts General Hospital
See details and how to joinNCT04230109 - Phase 1/2Taking peopleTrial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- Where
- Orange
- Age
- 18 years and over
- People
- 67
- Run by
- University of California, Irvine
See details and how to joinNCT07064018 - Phase 1/2Taking peopleStudy of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
- Where
- Houston
- Age
- 18 years and over
- People
- 31
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07011654 - Phase 1/2Taking peopleA Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Where
- Atlanta, Boston, Chicago, Dallas, Detroit, Fairfax, Houston, Jacksonville, Las Vegas, Nashville, New York, Oklahoma City, Orange, Phoenix, Rochester, Salt Lake City, San Francisco, Santa Monica, Sarasota, Seattle, Sioux Falls, Spokane, Tampa
- Age
- 18 years and over
- People
- 360
- Run by
- Day One Biopharmaceuticals, Inc.
See details and how to joinNCT05377996 - No phaseTaking peopleFeasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
- Where
- Cleveland, Columbus
- Age
- 18 years and over
- People
- 40
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT05677802 - No phaseTaking peoplePredicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Where
- Forth Worth, Fort Smith, Frederick, Oklahoma City, Springfield, St Louis, Temple
- Age
- 18 years and over
- People
- 2,000
- Run by
- Elephas
See details and how to joinNCT07327489 - No phaseNot yet taking people in United StatesStudy of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression
- Where
- Detroit
- Age
- 22 years and over
- People
- 24
- Run by
- Barbara Ann Karmanos Cancer Institute
See details and how to joinNCT07672431 - Phase 2Taking peopleCirculating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
- Where
- Nashville
- Age
- 18 years and over
- People
- 160
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT05770531 - Phase 1Taking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Austin, Chicago, Duarte, Durham, Fairfax, Fort Wayne, Grand Rapids, Houston, Huntersville, Indianapolis, Irvine, Irving, Los Angeles, Louisville, Minneapolis, Omaha, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - Phase 1Taking peopleBAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Ann Arbor, Atlanta, Coral Gables, Dallas, Houston, New Haven, New York, Portland, The Bronx
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- SillaJen, Inc.
See details and how to joinNCT05768932 - Phase 1Taking peopleMEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Where
- Durham, Tampa
- Age
- 18 years and over
- People
- 40
- Run by
- Memgen, Inc.
See details and how to joinNCT05076760 - Phase 2Taking peopleARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
- Where
- San Francisco
- Age
- 18 years and over
- People
- 36
- Run by
- Laura Huppert, MD, BA
See details and how to joinNCT06224673 - Phase 1Enrolling by invitationA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
- Where
- Grand Rapids, Houston, Huntersville, Myrtle Beach, Nashville, New Haven, New York, San Antonio, San Francisco, Seattle, West Valley City
- Age
- 18 years and over
- People
- 149
- Run by
- Rondo Therapeutics
See details and how to joinNCT07218003 - Phase 1Taking peopleDose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- Where
- Fort Worth, Los Angeles, West Valley City
- Age
- 18 years and over
- People
- 40
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT07517198 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Where
- Atlanta, Augusta, Baltimore, Camden, Charleston, Charlottesville, Chattanooga, Chicago, Cincinnati, Coral Gables, Detroit, Hilliard, Houston, Little Rock, Louisville, Nashville, New York, Palo Alto, Portland, Skokie, Tampa, Tucson
- Age
- 18 years and over
- People
- 182 worldwide
- Run by
- Eisai Inc.
See details and how to joinNCT04300556 · EU 2023-506868-14-00 - Phase 2Taking peopleAlpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
- Where
- Bethesda, Houston
- Age
- 18 years and over
- People
- 36
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT05660083 - Phase 2Taking peoplePropranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
- Where
- Atlanta, Buffalo
- Age
- 18 years and over
- People
- 37
- Run by
- Emory University
See details and how to joinNCT05741164 - Phase 2Not yet taking people in United StatesBlood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial
- Where
- Houston
- Age
- 18 years and over
- People
- 200
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07610525 - Phase 1/2Taking peopleSaci Nivo Rela for TNBC
- Where
- New Haven
- Age
- 18 years and over
- People
- 60
- Run by
- Yale University
See details and how to joinNCT06963905 - Phase 1Taking peopleA2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 20
- Run by
- University of Southern California
See details and how to joinNCT05989828 - Early phase 1Taking peopleNeoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 15
- Run by
- Rima Patel
See details and how to joinNCT06637306 - No phaseTaking peopleEvaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
- Where
- Atlanta
- Age
- 18 years and over
- People
- 10
- Run by
- Emory University
See details and how to joinNCT05877859 - Phase 2Taking peopleI-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Where
- Atlanta, Aurora, Birmingham, Buffalo, Chicago, Cleveland, Columbus, Dallas, Davis, Duarte, Falls Church, Houston, La Jolla, Lansing, Los Angeles, Maywood, Minneapolis, Nashville, New Brunswick, New Haven, Newport Beach, New York, Philadelphia, Pittsburgh, Portland, Rochester, Saint Louis Park, Salt Lake City, San Francisco, Scottsdale, Seattle, Sioux Falls, Tampa, The Bronx, Tucson, Washington D.C., Westwood, Winston-Salem
- Age
- 18 years and over
- People
- 5,000
- Run by
- QuantumLeap Healthcare Collaborative
See details and how to joinNCT01042379 - Phase 2Taking peopleNeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
- Where
- Charleston
- Age
- 18 years and over
- People
- 43
- Run by
- Medical University of South Carolina
See details and how to joinNCT06845319